303 related articles for article (PubMed ID: 34285312)
1. Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.
Moghnieh R; Abdallah D; Jadayel M; Zorkot W; El Masri H; Dib MJ; Omar T; Sinno L; Lakkis R; Jisr T
Sci Rep; 2021 Jul; 11(1):14757. PubMed ID: 34285312
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
[TBL] [Abstract][Full Text] [Related]
4. The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery.
Hoffman T; Lellouche J; Nutman A; Temkin E; Frenk S; Harbarth S; Carevic B; Cohen-Percia S; Kariv Y; Fallach N; Klausner J; Carmeli Y;
Clin Microbiol Infect; 2021 Oct; 27(10):1481-1487. PubMed ID: 33588061
[TBL] [Abstract][Full Text] [Related]
5. Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment.
Miller BM; Johnson SW
Am J Infect Control; 2016 Feb; 44(2):134-7. PubMed ID: 26492818
[TBL] [Abstract][Full Text] [Related]
6. [External Validation of Carbapenem-Resistant
Seo SM; Jeong IS
J Korean Acad Nurs; 2020 Aug; 50(4):621-630. PubMed ID: 32895347
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of carbapenem-resistant
Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
[No Abstract] [Full Text] [Related]
10. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
11. An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting.
Holmgren A; Ljung A; Bremell D
Infect Dis (Lond); 2020 Apr; 52(4):242-248. PubMed ID: 31868053
[No Abstract] [Full Text] [Related]
12. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
[TBL] [Abstract][Full Text] [Related]
14. Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.
Lin Q; Wang Y; Yu J; Li S; Zhang Y; Wang H; Lai X; Liu D; Mao L; Luo Y; Tang G; Chen Z; Sun Z
BMC Infect Dis; 2021 Jul; 21(1):638. PubMed ID: 34215214
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
Teo J; Cai Y; Tang S; Lee W; Tan TY; Tan TT; Kwa AL
PLoS One; 2012; 7(3):e34254. PubMed ID: 22461908
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors and clinical prognosis analysis of carbapenem-resistant
Zhang AR; Wang Q; Zhou CE; Zhang JG; Wang XJ; Zhao JK; Lu BH; Yang CX; Gu L; Ma LY; Su JR; Cao B; Wang H
Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(21):1572-1582. PubMed ID: 34098684
[No Abstract] [Full Text] [Related]
18. Carbapenem-resistant
Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
Front Public Health; 2022; 10():983174. PubMed ID: 36091556
[TBL] [Abstract][Full Text] [Related]
19. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH
Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.
Hassoun-Kheir N; Hussien K; Karram M; Saffuri M; Badaan S; Peleg S; Aboelhega W; Warman S; Alon T; Pollak D; Szwarcwort Cohen M; Paul M
Antimicrob Resist Infect Control; 2023 Nov; 12(1):129. PubMed ID: 37986092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]